Zscaler, Inc. Forecast, price target & analysts
Zscaler, Inc. Target price 2025 - Analyst rating & recommendation
Zscaler, Inc. Classifications & Recommendation:
Zscaler, Inc. Price Target
| Target Price | $321.30 |
| Price | $313.94 |
| Potential | 2.34% |
| Number of Estimates | 47 |
| 47 Analysts have issued a price target Zscaler, Inc. 2026 . The average Zscaler, Inc. target price is $321.30. This is 2.34% higher than the current stock price. The highest price target is $404.25 28.77% , the lowest is $217.15 30.83% . | |
| A rating was issued by 55 analysts: 41 Analysts recommend Zscaler, Inc. to buy, 14 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Zscaler, Inc. stock has an average upside potential 2026 of 2.34% . Most analysts recommend the Zscaler, Inc. stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
51 Analysts have issued a sales forecast Zscaler, Inc. 2025 . The average Zscaler, Inc. sales estimate is $2.7b . This is 7.63% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.8b 10.22% , the lowest is $2.6b 2.33% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $2.2b | 34.06% |
|---|---|---|
| 2025 | $2.7b | 26.44% |
| 2026 | $3.3b | 20.25% |
| 2027 | $3.9b | 19.81% |
| 2028 | $4.8b | 22.11% |
| 2029 | $5.8b | 19.97% |
| 2030 | $6.9b | 18.96% |
| 2031 | $8.1b | 18.41% |
| 2032 | $9.6b | 17.87% |
21 Analysts have issued an Zscaler, Inc. EBITDA forecast 2025. The average Zscaler, Inc. EBITDA estimate is $689m . This is 668.59% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $777m 741.95% , the lowest is $622m 613.26% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-120m | 46.90% |
|---|---|---|
| 2025 | $689m | 675.14% |
| 2026 | $869m | 26.17% |
| 2027 | $1.1b | 22.58% |
EBITDA Margin
| 2024 | -5.52% | 60.39% |
|---|---|---|
| 2025 | 25.12% | 554.81% |
| 2026 | 26.36% | 4.94% |
| 2027 | 26.97% | 2.31% |
50 Zscaler, Inc. Analysts have issued a net profit forecast 2025. The average Zscaler, Inc. net profit estimate is $512m . This is 1,419.75% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $533m 1,474.32% , the lowest is $485m 1,351.21% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-57.7m | 71.47% |
|---|---|---|
| 2025 | $512m | 986.85% |
| 2026 | $588m | 14.82% |
| 2027 | $714m | 21.55% |
| 2028 | $911m | 27.53% |
| 2029 | $1.1b | 22.89% |
| 2030 | $1.4b | 24.14% |
| 2031 | $1.9b | 33.18% |
| 2032 | $2.4b | 29.55% |
Net Margin
| 2024 | -2.66% | 78.72% |
|---|---|---|
| 2025 | 18.67% | 801.30% |
| 2026 | 17.83% | 4.50% |
| 2027 | 18.09% | 1.46% |
| 2028 | 18.89% | 4.42% |
| 2029 | 19.35% | 2.44% |
| 2030 | 20.19% | 4.34% |
| 2031 | 22.71% | 12.48% |
| 2032 | 24.96% | 9.91% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
50 Analysts have issued a Zscaler, Inc. forecast for earnings per share. The average Zscaler, Inc. EPS is $3.29 . This is 1,365.38% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.42 1,415.38% , the lowest is $3.12 1,300.00% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-0.39 | 72.14% |
|---|---|---|
| 2025 | $3.29 | 943.59% |
| 2026 | $3.77 | 14.59% |
| 2027 | $4.59 | 21.75% |
| 2028 | $5.85 | 27.45% |
| 2029 | $7.19 | 22.91% |
| 2030 | $8.92 | 24.06% |
| 2031 | $11.89 | 33.30% |
| 2032 | $15.40 | 29.52% |
P/E ratio
| Current | -1,207.46 | 195.28% |
|---|---|---|
| 2025 | 95.51 | 107.91% |
| 2026 | 83.18 | 12.91% |
| 2027 | 68.43 | 17.73% |
| 2028 | 53.66 | 21.58% |
| 2029 | 43.67 | 18.62% |
| 2030 | 35.18 | 19.44% |
| 2031 | 26.41 | 24.93% |
| 2032 | 20.39 | 22.79% |
Based on analysts' sales estimates for 2025, the Zscaler, Inc. stock is valued at an EV/Sales of 17.16 and an P/S ratio of 17.83 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 18.46 | 34.06% |
|---|---|---|
| 2025 | 17.16 | 7.07% |
| 2026 | 14.27 | 16.84% |
| 2027 | 11.91 | 16.54% |
| 2028 | 9.75 | 18.10% |
| 2029 | 8.13 | 16.65% |
| 2030 | 6.83 | 15.94% |
| 2031 | 5.77 | 15.55% |
| 2032 | 4.90 | 15.16% |
P/S ratio
| Current | 19.19 | 34.11% |
|---|---|---|
| 2025 | 17.83 | 7.09% |
| 2026 | 14.83 | 16.84% |
| 2027 | 12.38 | 16.54% |
| 2028 | 10.14 | 18.10% |
| 2029 | 8.45 | 16.65% |
| 2030 | 7.10 | 15.94% |
| 2031 | 6.00 | 15.55% |
| 2032 | 5.09 | 15.16% |
Current Zscaler, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Jun 27 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Jun 16 2025 |
| Wells Fargo |
Equal-Weight
➜
Overweight
|
Upgrade | Jun 13 2025 |
| Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Jun 11 2025 |
| B of A Securities |
Buy
➜
Buy
|
Unchanged | Jun 09 2025 |
| Oppenheimer |
Outperform
➜
Outperform
|
Unchanged | Jun 06 2025 |
| Scotiabank |
Sector Outperform
➜
Sector Outperform
|
Unchanged | Jun 06 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Jun 27 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Jun 16 2025 |
|
Upgrade
Wells Fargo:
Equal-Weight
➜
Overweight
|
Jun 13 2025 |
|
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Jun 11 2025 |
|
Unchanged
B of A Securities:
Buy
➜
Buy
|
Jun 09 2025 |
|
Unchanged
Oppenheimer:
Outperform
➜
Outperform
|
Jun 06 2025 |
|
Unchanged
Scotiabank:
Sector Outperform
➜
Sector Outperform
|
Jun 06 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
